Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Cumulative evidence indicates that mitochondrial dysfunction has a role in heart failure progression, but whether mitochondrial quality control mechanisms are involved in the development of cardiac dysfunction remains unclear. Here we show that cytosolic p53 impairs autophagic degradation of damaged mitochondria and facilitates mitochondrial dysfunction and heart failure in mice. Prevalence and induction of mitochondrial autophagy is attenuated by senescence or doxorubicin treatment in vitro and in vivo. We show that cytosolic p53 binds to Parkin and disturbs its translocation to damaged mitochondria and their subsequent clearance by mitophagy. p53-deficient mice show less decline of mitochondrial integrity and cardiac functional reserve with increasing age or after treatment with doxorubicin. Furthermore, overexpression of Parkin ameliorates the functional decline in aged hearts, and is accompanied by decreased senescence-associated β-galactosidase activity and proinflammatory phenotypes. Thus, p53-mediated inhibition of mitophagy modulates cardiac dysfunction, raising the possibility that therapeutic activation of mitophagy by inhibiting cytosolic p53 may ameliorate heart failure and symptoms of cardiac ageing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Defective mitophagy has also been linked with premature aging and many age-associated disorders, such as Alzheimer’s and Parkinson’s diseases (25–28).”
From Impaired mitophagy leads to cigarette smoke stress‐induced cellular senescence: implications for chronic obstructive pulmonary disease (2015) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recent study has shown that increased p53 cytosolic localization prevents Parkin translocation to mitochondria during organismal aging (27).”
From Impaired mitophagy leads to cigarette smoke stress‐induced cellular senescence: implications for chronic obstructive pulmonary disease (2015) · cites this paper as [27]
Experimental — accuracy not yet measuredIn the citing paper
“| Cardiomyopathies | Whole‐body deletion of Tp53 | Decelerated cardiac aging, linked to improved mitophagic responses after stabilization of PRKN | Hoshino et al (2013) |”
From Autophagy in major human diseases (2021) · cites this paper as Hoshino et al (2013)
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026
Youle, R. J., & Narendra, D. P. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3028 · Cited by 3,273
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Geisler, S., Holmström, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., & Springer, W. (2010) · Nature Cell Biology · doi:10.1038/ncb2012 · Cited by 2,835
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734
The Failing Heart — An Engine Out of Fuel
Neubauer, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra063052 · Cited by 2,417
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
Cited by
Hallmarks of Cellular Senescence
Hernandez-Segura, A., Nehme, J., & Demaria, M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.02.001 · Cited by 2,605
“By contrast, cytoplasmic p53 interacts with Parkin, inhibiting its translocation to damaged mitochondria in doxorubicin-induced senescence in cardiomyocytes [148].”
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Mechanisms of mitophagy in cellular homeostasis, physiology and pathology
Palikaras, K., Lionaki, E., & Tavernarakis, N. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0176-2 · Cited by 1,472
Mitochondrial dynamics and mitochondrial quality control
Ni, H.-M., Williams, J. A., & Ding, W.-X. (2015) · Redox Biology · doi:10.1016/j.redox.2014.11.006 · Cited by 931
“Overexpression of Parkin attenuated functional decline of aged hearts [70].”
BackgroundAutophagy and mitophagy in cardiovascular disease
Bravo-San Pedro, J. M., Kroemer, G., & Galluzzi, L. (2017) · Circulation Research · doi:10.1161/circresaha.117.311082 · Cited by 843
“Trp53 mice preserved superior cardiac functional reserve with increasing age when compared with their wild-type (WT) counterparts, a phenotype that has been linked to the ability of cytosolic TRP53 (transformation-related protein 53, best known as p53) to inhibit PARK2 (Parkinson disease [autosomal recessive, juvenile…”
ResultMitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy
Wallace, K. B., Sardão, V. A., & Oliveira, P. J. (2020) · Circulation Research · doi:10.1161/circresaha.119.314681 · Cited by 599
PINK1/Parkin-mediated mitophagy in mammalian cells
Eiyama, A., & Okamoto, K. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.01.002 · Cited by 603
The Role of Autophagy in the Heart
Sciarretta, S., Maejima, Y., Zablocki, D., & Sadoshima, J. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021317-121427 · Cited by 547
p53 in ferroptosis regulation: The new weapon for the old guardian
Liu, Y., & Gu, W. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00943-y · Cited by 540
“However, there is also a study reporting an inhibitory effect of p53 on Parkin activity [50].”
BackgroundMitochondrial autophagy: molecular mechanisms and implications for cardiovascular disease
Li, A., Gao, M., Liu, B., Qin, Y., chen, L., Liu, H., Wu, H., & Gong, G. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04906-6 · Cited by 456
“Cytosolic p53 impairs mitophagy by binding with Parkin to disturb subsequent clearance of damaged mitochondria and further facilitates cardiac dysfunction and HF [169].”
BackgroundMolecular machinery and interplay of apoptosis and autophagy in coronary heart disease
Dong, Y., Chen, H., Gao, J., Liu, Y., Li, J., & Wang, J. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.09.001 · Cited by 438
Role of Cardiolipin in Mitochondrial Signaling Pathways
Dudek, J. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00090 · Cited by 428
“Mitophagy plays an essential role during cardiac development and maintains cardiac function in the adult heart (Billia et al., 2011; Hoshino et al., 2013; Kubli et al., 2013; Gong et al., 2015).”
BackgroundMitochondria and ageing: Role in heart, skeletal muscle and adipose tissue
Boengler, K., Kosiol, M., Mayr, M., Schulz, R., & Rohrbach, S. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12178 · Cited by 421
“Indeed, decreased numbers of mitochondria incorporated in autophagosomes are observed in aged mouse hearts.(93) Here, the protein expression of Pink2 and Parkin is similar in young and aged hearts; however, the translocation of Parkin is reduced with ageing.”
BackgroundInfluentialHamacher-Brady, A., & Brady, N. R. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2087-8 · Cited by 397
“In addition, nuclear p53 upregulates Parkin expression [113], while cytosolic p53 suppresses Parkin targeting of mitochondria [114], and Parkin suppresses p53 expression [115], suggesting a multi-tiered homeostatic feedback.”
BackgroundMitochondrial quality control mechanisms as molecular targets in cardiac ageing
Picca, A., Mankowski, R. T., Burman, J. L., Donisi, L., Kim, J.-S., Marzetti, E., & Leeuwenburgh, C. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0059-z · Cited by 387
Nuclear DNA damage signalling to mitochondria in ageing
Fang, E. F., Scheibye-Knudsen, M., Chua, K. F., Mattson, M. P., Croteau, D. L., & Bohr, V. A. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.14 · Cited by 387
The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics
Panigrahi, D. P., Praharaj, P. P., Bhol, C. S., Mahapatra, K. K., Patra, S., Behera, B. P., Mishra, S. R., & Bhutia, S. K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.015 · Cited by 362
Höhn, A., Weber, D., Jung, T., Ott, C., Hugo, M., Kochlik, B., Kehm, R., König, J., Grune, T., & Castro, J. P. (2017) · Redox Biology · doi:10.1016/j.redox.2016.12.001 · Cited by 366
Senescence mechanisms and targets in the heart
Chen, M. S., Lee, R. T., & Garbern, J. C. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvab161 · Cited by 327
Cellular senescence: all roads lead to mitochondria
Martini, H., & Passos, J. F. (2023) · The FEBS Journal · doi:10.1111/febs.16361 · Cited by 334
Autophagy in cardiovascular biology
Lavandero, S., Chiong, M., Rothermel, B. A., & Hill, J. A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci73943 · Cited by 331
“Hoshino et al. showed that cytosolic p53 impairs autophagic degradation of damaged mitochondria, triggering mitochondrial dysfunction and HF in mice (72).”
Mitochondrial dysfunction and cell senescence: deciphering a complex relationship
Chapman, J., Fielder, E., & Passos, J. F. (2019) · FEBS Letters · doi:10.1002/1873-3468.13498 · Cited by 325
Molecular Mechanisms of Mitochondrial Autophagy/Mitophagy in the Heart
Saito, T., & Sadoshima, J. (2015) · Circulation Research · doi:10.1161/circresaha.116.303790 · Cited by 322
“Because p53-deficient mice exhibit less of a decline in mitochondrial integrity and cardiac reserve during aging, it is possible that endogenous Parkin may play an important role in mediating mitophagy and that Parkin-mediated mitophagy declines with aging, in part because of p53.(89) Whether endogenous Pink1 plays an…”
The pharmacological regulation of cellular mitophagy
Georgakopoulos, N. D., Wells, G., & Campanella, M. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2287 · Cited by 319
How mitochondrial dynamism orchestrates mitophagy
Shirihai, O. S., Song, M., & Dorn, G. W. (2015) · Circulation Research · doi:10.1161/circresaha.116.306374 · Cited by 311
Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
Koleini, N., & Kardami, E. (2017) · Oncotarget · doi:10.18632/oncotarget.16944 · Cited by 301
“It should be noted that Hoshino and colleagues [52]”
BackgroundInfluentialTargeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles
Bonora, M., Wieckowski, M. R., Sinclair, D. A., Kroemer, G., Pinton, P., & Galluzzi, L. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0074-0 · Cited by 294
Mesenchymal Stem/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating Strategies
Weng, Z., Wang, Y., Ouchi, T., Liu, H., Qiao, X., Wu, C., Zhao, Z., Li, L., & Li, B. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac004 · Cited by 285
Zhan, M., Usman, I. M., Sun, L., & Kanwar, Y. S. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014050457 · Cited by 288
Hallmarks of cardiovascular ageing
Abdellatif, M., Rainer, P. P., Sedej, S., & Kroemer, G. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00881-3 · Cited by 274
Nuclear genomic instability and aging
Niedernhofer, L. J., Gurkar, A. U., Wang, Y., Vijg, J., Hoeijmakers, J. H. J., & Robbins, P. D. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012239 · Cited by 275
Yao, J., Wang, J., Xu, Y., Guo, Q., Sun, Y., Liu, J., Li, S., Guo, Y., & Wei, L. (2022) · Autophagy · doi:10.1080/15548627.2021.2007027 · Cited by 267
“TP53 facilitates mitochondrial dysfunction and disturbs the clearance of damaged mitochondria by mitophagy [16,17].”
BackgroundAhmad, T., Sundar, I. K., Lerner, C. A., Gerloff, J., Tormos, A. M., Yao, H., & Rahman, I. (2015) · The FASEB Journal · doi:10.1096/fj.14-268276 · Cited by 264
“Cytosolic p53 (catalog number 2524; Cell Signaling Technology) can interact with Parkin, which inhibits Parkin mitochondrial translocation in aged cardiomyocytes (27).”
BackgroundThe complexity of p53-mediated metabolic regulation in tumor suppression
Liu, Y., & Gu, W. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.010 · Cited by 261
Wu, L., Wang, L., Du, Y., Zhang, Y., & Ren, J. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.10.003 · Cited by 257
Mitophagy in cardiovascular diseases: molecular mechanisms, pathogenesis, and treatment
Ajoolabady, A., Chiong, M., Lavandero, S., Klionsky, D. J., & Ren, J. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.06.007 · Cited by 258
Riegger, J., Schoppa, A., Ruths, L., Haffner-Luntzer, M., & Ignatius, A. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00489-y · Cited by 235
Pleiotropic effects of mitochondria in aging
Lima, T., Li, T. Y., Mottis, A., & Auwerx, J. (2022) · Nature Aging · doi:10.1038/s43587-022-00191-2 · Cited by 236
Autophagy in Cardiovascular Aging
Abdellatif, M., Sedej, S., Carmona-Gutierrez, D., Madeo, F., & Kroemer, G. (2018) · Circulation Research · doi:10.1161/circresaha.118.312208 · Cited by 239
“respiratory function of cardiac mitochondria, as well as with reduced oxidative stress and proinflammatory cytokines.(128)”
BackgroundEvolving and Expanding the Roles of Mitophagy as a Homeostatic and Pathogenic Process
Gustafsson, Å. B., & Dorn, G. W. (2019) · Physiological Reviews · doi:10.1152/physrev.00005.2018 · Cited by 228
The ADP/ATP translocase drives mitophagy independent of nucleotide exchange
Hoshino, A., Wang, W.-J., Wada, S., McDermott-Roe, C., Evans, C. S., Gosis, B., Morley, M. P., Rathi, K. S., Li, J., Li, K., et al. (2019) · Nature · doi:10.1038/s41586-019-1667-4 · Cited by 228
Self-citationLaw, B. A., Liao, X., Moore, K. S., Southard, A., Roddy, P., Ji, R., Szulc, Z., Bielawska, A., Schulze, P. C., & Cowart, L. A. (2018) · The FASEB Journal · doi:10.1096/fj.201700300r · Cited by 221
“In HF there is an acute increase in circulating levels of fatty acids due to insulin resistance and increased peripheral lipolysis (34), which oversupplies cardiomyocytes with substrate formitochondrial oxidation and increasesROS.”
BackgroundInfluentialThe role of mitochondrial dynamics in cardiovascular diseases
Forte, M., Schirone, L., Ameri, P., Basso, C., Catalucci, D., Modica, J., Chimenti, C., Crotti, L., Frati, G., Rubattu, S., et al. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15068 · Cited by 216
Mitochondrial dynamics as regulators of cancer biology
Trotta, A. P., & Chipuk, J. E. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2451-3 · Cited by 222
“Moreover, p53 inhibits PARKIN-mediated mitophagy in mouse heart and pancreatic β cells, suggesting a role for p53 in the regulation of energy metabolism, although this particular function has yet to be investigated in cancer cells [78, 79].”
Autophagic dysregulation in doxorubicin cardiomyopathy
Bartlett, J. J., Trivedi, P. C., & Pulinilkunnil, T. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.01.007 · Cited by 214
Cardiomyocyte Senescence and Cellular Communications Within Myocardial Microenvironments
Tang, X., Li, P.-H., & Chen, H.-Z. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00280 · Cited by 216
“P53 also inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction to facilitate cellular senescence (31).”
BackgroundShao, D., Kolwicz, S. C., Wang, P., Roe, N. D., Villet, O., Nishi, K., Hsu, Y.-W. A., Flint, G. V., Caudal, A., Wang, W., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.043319 · Cited by 217
A Rab5 endosomal pathway mediates Parkin-dependent mitochondrial clearance
Hammerling, B. C., Najor, R. H., Cortez, M. Q., Shires, S. E., Leon, L. J., Gonzalez, E. R., Boassa, D., Phan, S., Thor, A., Jimenez, R. E., et al. (2017) · Nature Communications · doi:10.1038/ncomms14050 · Cited by 222
Inhibition of p53 preserves Parkin-mediated mitophagy and pancreatic β-cell function in diabetes
Hoshino, A., Ariyoshi, M., Okawa, Y., Kaimoto, S., Uchihashi, M., Fukai, K., Iwai-Kanai, E., Ikeda, K., Ueyama, T., Ogata, T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318951111 · Cited by 215
“Conversely, cytosolic p53 has been shown to disturb the clearance of damaged mitochondria by an inhibitory interaction with Parkin (9).”
BackgroundSelf-citationSIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer's disease
Lee, J., Kim, Y., Liu, T., Hwang, Y. J., Hyeon, S. J., Im, H., Lee, K., Alvarez, V. E., McKee, A. C., Um, S., et al. (2018) · Aging Cell · doi:10.1111/acel.12679 · Cited by 213
“proteins such as CHCHD4, OGG1, Parkin, POLG, and TFAM (Achanta & Huang, 2004; Achanta et al., 2005; and Wong et al., 2009; Hoshino et al., 2013; Zhuang et al., 2013).”
BackgroundLi, M., Sala, V., De Santis, M. C., Cimino, J., Cappello, P., Pianca, N., Di Bona, A., Margaria, J. P., Martini, M., Lazzarini, E., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.030352 · Cited by 207
Autophagy and mitophagy in diabetic cardiomyopathy
Kobayashi, S., & Liang, Q. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.020 · Cited by 205
“For instance, overexpression of Parkin is sufficient to inducemitophagywhenmitochondria lose theirmembrane potential [104] and to prevent cardiac dysfunction in agedmice [100].”
BackgroundHenstridge, D. C., Bruce, C. R., Drew, B. G., Tory, K., Kolonics, A., Estevez, E., Chung, J., Watson, N., Gardner, T., Lee-Young, R. S., et al. (2014) · Diabetes · doi:10.2337/db13-0967 · Cited by 201
“Of note, p53 has recently been shown to inhibit parkin-mediated mitophagy (38).”
BackgroundMitophagy, Mitochondrial Dynamics, and Homeostasis in Cardiovascular Aging
Wu, N. N., Zhang, Y., & Ren, J. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9825061 · Cited by 197
Mitochondrial quality control in human health and disease
Liu, B.-H., Xu, C.-Z., Liu, Y., Lu, Z.-L., Fu, T.-L., Li, G.-R., Deng, Y., Luo, G.-Q., Ding, S., Li, N., et al. (2024) · Military Medical Research · doi:10.1186/s40779-024-00536-5 · Cited by 171
Mitophagy and Oxidative Stress: The Role of Aging
De Gaetano, A., Gibellini, L., Zanini, G., Nasi, M., Cossarizza, A., & Pinti, M. (2021) · Antioxidants · doi:10.3390/antiox10050794 · Cited by 184
“Mitophagy decline with aging has been observed in different tissues either from humans or mice, including (but not limited to) myocardium [81] skeletal muscle [82,83] skeletal muscle satellite cells [84], dentate gyrus [85], cultured fibroblasts [86].”
BackgroundMetabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications
Xie, S., Xu, S.-C., Deng, W., & Tang, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01378-8 · Cited by 177
Mitochondria: a therapeutic target in acute kidney injury
Ishimoto, Y., & Inagi, R. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv317 · Cited by 184
Preventing and Treating Anthracycline Cardiotoxicity: New Insights
Sawicki, K. T., Sala, V., Prever, L., Hirsch, E., Ardehali, H., & Ghigo, A. (2021) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-030620-104842 · Cited by 177
Stress-induced biological aging: A review and guide for research priorities
Polsky, L. R., Rentscher, K. E., & Carroll, J. E. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.05.016 · Cited by 165
Doxorubicin‐induced cardiomyocyte death is mediated by unchecked mitochondrial fission and mitophagy
Catanzaro, M. P., Weiner, A., Kaminaris, A., Li, C., Cai, F., Zhao, F., Kobayashi, S., Kobayashi, T., Huang, Y., Sesaki, H., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802663r · Cited by 174
“Dox was reported to inhibit cardiac mitophagy because of the sequestration of parkin by p53 that led to decreased mitochondrial translocation of parkin and reduced mitochondria incorporation into autophagic vacuoles (34).”
BackgroundMethodEmerging role of mitophagy in cardiovascular physiology and pathology
Morales, P. E., Arias-Durán, C., Ávalos-Guajardo, Y., Aedo, G., Verdejo, H. E., Parra, V., & Lavandero, S. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.09.006 · Cited by 178
“membrane potential and promoting the accumulation of dysfunctional mitochondria (Hoshino et al., 2013).”
BackgroundInfluentialCadete, V. J. J., Deschênes, S., Cuillerier, A., Brisebois, F., Sugiura, A., Vincent, A., Turnbull, D., Picard, M., McBride, H. M., & Burelle, Y. (2016) · The Journal of Physiology · doi:10.1113/jp272703 · Cited by 179
“To determine whether MDV production occurs in vivo, a commonly used model of acute doxorubicin cardiotoxicity was used in C57BL/6 mice (Diotte et al. 2009; Zhang et al. 2009; Kawaguchi et al. 2012; Hoshino et al. 2013).”
MethodPalikaras, K., Daskalaki, I., Markaki, M., & Tavernarakis, N. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.04.005 · Cited by 171
“…increased numbers of mitochondria and greater levels of oxidative stress have been observed in cardiomyocytes of PINK1 and Parkin deficient mice, leading to deterioration of cardiac function (Billia et al., 2011; Hoshino et al., 2013; Kubli et al., 2013a; Kubli et al., 2013b; Siddall et al., 2013).”
BackgroundZhang, X., Wang, Q., Wang, X., Chen, X., Shao, M., Zhang, Q., Guo, D., Wu, Y., Li, C., Wang, W., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108599 · Cited by 170
p53 and mitochondrial function in neurons
Wang, D. B., Kinoshita, C., Kinoshita, Y., & Morrison, R. S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.12.015 · Cited by 167
“Hoshino A, Matoba S, Iwai-Kanai E, Nakamura H, Kimata M, Nakaoka M, Katamura M, Okawa Y, Ariyoshi M, Mita Y, Ikeda K, Ueyama T, Okigaki M, Matsubara H. p53-TIGAR axis attenuates mitophagy to exacerbate cardiac damage after ischemia.”
BackgroundInfluentialp53 Deacetylation Alleviates Sepsis-Induced Acute Kidney Injury by Promoting Autophagy
Sun, M., Li, J., Mao, L., Wu, J., Deng, Z., He, M., An, S. L., Zeng, Z., Huang, Q., & Chen, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.685523 · Cited by 177
Mitochondrial dynamics and cell death in heart failure
Marín-García, J., & Akhmedov, A. T. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9530-2 · Cited by 169
“Mitophagy induced by cardiac stress removes damaged dysfunctional mitochondria preventing thereby oxidative damage, which can otherwise initiate apoptosis and ultimately HF [122, 123].”
Therapeutic Targeting of Autophagy: Potential and Concerns in Treating Cardiovascular Disease
Orogo, A. M., & Gustafsson, Å. B. (2015) · Circulation Research · doi:10.1161/circresaha.116.303791 · Cited by 166
“Interestingly, transgenic mice overexpressing Parkin in cardiomyocytes are more resistant to age-dependent mitochondrial alterations compared with age-matched WT mice, suggesting that increasing mitophagy can delay aging.(24) Thus, simply increasing baseline autophagy or mitophagy can ameliorate cardiac aging.”
BackgroundInfluentialMitochondrial contribution to lipofuscin formation
König, J., Ott, C., Hugo, M., Jung, T., Bulteau, A.-L., Grune, T., & Höhn, A. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.017 · Cited by 152
“Furthermore, it was shown that the accumulation of dysfunctional mitochondria results in elevated ROS formation [23,50] and is therefore an explanation for the observation of higher lipofuscin amounts in our cellular models.”
MitophAging: Mitophagy in Aging and Disease
Bakula, D., & Scheibye-Knudsen, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00239 · Cited by 148
Autophagy in health and disease: focus on the cardiovascular system
Mialet‐Perez, J., & Vindis, C. (2017) · Essays in Biochemistry · doi:10.1042/ebc20170022 · Cited by 154
Mitochondrial dynamism and heart disease: changing shape and shaping change
Dorn, G. W. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404575 · Cited by 146
“Nevertheless, modest cardiac and cardiomyocyte mitochondrial abnormalities were detected in 1-year-old Parkin null mice (Hoshino et al, 2013; Kubli et al, 2013).”
BackgroundMitochondrial dysfunction and mitochondrial therapies in heart failure
Wu, C., Zhang, Z., Zhang, W., & Liu, X. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106038 · Cited by 152
Li, W., Jiang, W., Su, Y., Tu, K.-W., Zou, L., Liao, C., Wu, Q., Wang, Z., Zhong, Z., Chen, J., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05595-5 · Cited by 151
“It was reported that Parkin-deficient mice accumulated damaged mitochondria in aging heart, while cardiac specific over-expression of Parkin delayed cardiac aging by enhancing mitophagy [32].”
Backgroundp53 as guardian of the mitochondrial genome
Park, J., Zhuang, J., Li, J., & Hwang, P. M. (2016) · FEBS Letters · doi:10.1002/1873-3468.12061 · Cited by 143
Manna, S., McCarthy, C., & McCarthy, F. P. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3095383 · Cited by 141
“Furthermore, loss of mitochondrial biogenesis through an imbalance of mitophagy and mitochondrial fission/fusion and accumulation of mitochondrial debris leads to cardiac ageing in mice [39, 40].”
BackgroundOsataphan, N., Phrommintikul, A., Chattipakorn, S. C., & Chattipakorn, N. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15305 · Cited by 152
Autophagy and cardiac diseases: Therapeutic potential of natural products
Wu, X., Liu, Z., Yu, X., Xu, S., & Luo, J. (2020) · Medicinal Research Reviews · doi:10.1002/med.21733 · Cited by 142
“It has been recently reported that by inducing mitophagy, Tp53 animals are less sensitive to DOX‐driven cardiotoxicity than the wide‐type controls.(117) Another study, however, found that mitophagy inhibition by mdivi‐1 limits the cardiotoxic effects of DOX in cardiac I/R injury model.”
BackgroundMyocardial ischemia-reperfusion injury; Molecular mechanisms and prevention
Liu, Y., Li, L., Wang, Z., Zhang, J., & Zhou, Z. (2023) · Microvascular Research · doi:10.1016/j.mvr.2023.104565 · Cited by 163
Mitophagy mechanisms and role in human diseases
Redmann, M., Dodson, M., Boyer-Guittaut, M., Darley-Usmar, V., & Zhang, J. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.05.010 · Cited by 135
Danan, S., Wang, J., Toan, S., Muid, D., Li, R., Chang, X., & Zhou, H. (2022) · Angiogenesis · doi:10.1007/s10456-022-09835-8 · Cited by 136
Nishimura, A., Shimauchi, T., Tanaka, T., Shimoda, K., Toyama, T., Kitajima, N., Ishikawa, T., Shindo, N., Numaga-Tomita, T., Yasuda, S., et al. (2018) · Science Signaling · doi:10.1126/scisignal.aat5185 · Cited by 136
“Moreover, p53, a key mediator of senescence, accumulates in aged heart and promotes mitochondrial dysfunction by inhibiting Parkin-mediated mitophagy, leading to cardiac dysfunction (14).”
BackgroundMethodLi, Y., Chen, H., Wu, Q., & Xie, K. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4264 · Cited by 153
Shires, S. E., & Gustafsson, Å. B. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1254-6 · Cited by 133
“Overexpression of Parkin in tissues has been shown to reduce age-associated cardiac dysfunction, increase life span, and preservemitochondrial function inmice [6, 97].”
InfluentialThe regulatory roles of p53 in cardiovascular health and disease
Men, H., Cai, H., Cheng, Q., Zhou, W., Wang, X., Huang, S., Zheng, Y., & Cai, L. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03694-6 · Cited by 137
Xu, H.-X., Cui, S., Zhang, Y., & Ren, J. T. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0476-5 · Cited by 135
Forini, F., Kusmic, C., Nicolini, G., Mariani, L., Zucchi, R., Matteucci, M., Iervasi, G., & Pitto, L. (2014) · Endocrinology · doi:10.1210/en.2014-1106 · Cited by 132
“In contrast, supra-physiological levels of p53 have the opposite effect on mitochondrial integrity and biogenesis (20, 41).”
Inducing mitophagy in diabetic platelets protects against severe oxidative stress
Lee, S. H., Du, J., Stitham, J., Atteya, G. A., Lee, S., Xiang, Y., Wang, D., Jin, Y., Leslie, K. L., Spollett, G. R., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201506046 · Cited by 134
“The increased phosphorylated p53 and its translocation to mitochondria is an indicator and instigator for mitochondrial damage in DM platelets (Tang et al, 2014) and other organs (Tasdemir et al, 2008; Hoshino et al, 2013).”
BackgroundMitochondrial dysfunction and skeletal muscle atrophy: Causes, mechanisms, and treatment strategies
Kubat, G. B., Bouhamida, E., Ülger, Ö., Türkel, İ., Pedriali, G., Ramaccini, D., Ekinci, Ö., Özerkliğ, B., Atalay, Ö., Patergnani, S., et al. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.07.003 · Cited by 137
Mitoconfusion: Noncanonical Functioning of Dynamism Factors in Static Mitochondria of the Heart
Song, M., & Dorn, G. W. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.019 · Cited by 132
“Likewise, mice lacking Parkin develop structurally and functionally abnormal mitochondria and associated age-dependent cardiac abnormalities resembling premature senescence (Hoshino et al., 2013; Kubli et al., 2013a, 2013b).”
InfluentialTocchetti, C. G., Dessalvi, C. C., Lisi, D. D., Femminò, S., Madonna, R., Mele, D., Monte, I. P., Novo, G., Penna, C. R. R., Pepe, A., et al. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6930 · Cited by 142
“Recent observations in p53-null mice found a smaller impairment in cardiac functional reserve after ANT treatment, supporting this hypothesis (157).”
Nrf2 protects mitochondrial decay by oxidative stress
Strom, J., Xu, B., Tian, X., & Chen, Q. M. (2016) · The FASEB Journal · doi:10.1096/fj.14-268904 · Cited by 123
“augmentation of the mitophagic pathways can restore mitochondrial function and metabolic capacity (57).”
BackgroundP53 in kidney injury and repair: Mechanism and therapeutic potentials
Tang, C., Ma, Z., Zhu, J., Liu, Z., Liu, Y., Liu, Y., Cai, J., & Dong, Z. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.10.013 · Cited by 131
Mitophagy for cardioprotection
Titus, A. S., Sung, E., Zablocki, D., & Sadoshima, J. (2023) · Basic Research in Cardiology · doi:10.1007/s00395-023-01009-x · Cited by 132
“On the other hand, the anti-apoptotic Bcl-2 family proteins, Bcl-xL and Mcl-1 (in HeLa cells), and the tumor suppressor protein, p53 (in liver and heart), prevent Parkin translocation to mitochondria [59, 60, 62, 213].”
BackgroundPathophysiology of heart failure and frailty: a common inflammatory origin?
Bellumkonda, L., Tyrrell, D. J., Hummel, S. L., & Goldstein, D. R. (2017) · Aging Cell · doi:10.1111/acel.12581 · Cited by 132
“An experimental study found that defects in clearing defective mitochondria (i.e., a process termed mitophagy Lemasters, 2005) within the myocardium leads to mitochondrial dysfunction (Hoshino et al., 2013).”
BackgroundMolecular Regulation Mechanisms and Interactions Between Reactive Oxygen Species and Mitophagy
Fan, P., Xie, X.-H., Chen, C., Peng, X., Zhang, P., Yang, C. H., & Wang, Y. (2018) · DNA and Cell Biology · doi:10.1089/dna.2018.4348 · Cited by 127
“Hoshino et al. (2013) found that cytosolic p53, mitophagy-negative regulatory factor, facilitates mitochondrial dysfunction and heart failure in mice models.”
Zhang, F., Peng, W., Zhang, J., Dong, W., Wu, J., Wang, T., & Xie, Z. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2238-1 · Cited by 130
Varela‐López, A., Battino, M. A., Navarro‐Hortal, M. D., Giampieri, F., Forbes-Hernández, T. Y., Romero‐Márquez, J. M., Collado, R., & Quiles, J. L. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110834 · Cited by 133
Wei, F., Zhou, B., Suzuki, T., Miyata, K., Ujihara, Y., Horiguchi, H., Takahashi, N., Xie, P., Michiue, H., Fujimura, A., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.019 · Cited by 129
Metadata
- Authors
- Hoshino, A., Mita, Y., Okawa, Y., Ariyoshi, M., Iwai-Kanai, E., Ueyama, T., Ikeda, K., Ogata, T., & Matoba, S.
- Affiliations
- Kyoto Prefectural University (JP)
- Corresponding author
- Matoba, Satoaki
- Venue
- Nature Communications
- Published
- 2013-08-06
- Volume
- 4
- Issue
- 1
- Pages
- 2308-2308
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2030548258
- Cited by
- 536
- References
- 54
- Citations by year
- 2026: 22 · 2025: 30 · 2024: 53 · 2023: 48 · 2022: 68 · 2021: 50 · 2020: 58 · 2019: 42 · 2018: 36 · 2017: 52 · 2016: 23 · 2015: 29 · 2014: 22 · 2013: 1
- FWCI
- 18.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Communications (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- Parkin, mitophagy, mitochondrial dysfunction, heart failure, cardiac aging, mitochondrial quality control, autophagy, cellular senescence, doxorubicin cardiotoxicity, cardiac dysfunction
- MeSH terms
- Aging, Animals, Cytosol, Doxorubicin, Embryo, Mammalian, Fibroblasts, Heterozygote, Humans, Mice, Transgenic, Mitochondria, Myocardium, Protein Binding, Tumor Suppressor Protein p53, Cellular Senescence, Protein Structure, Tertiary, Protein Transport, Ubiquitin-Protein Ligases, HCT116 Cells, Mice, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.